Gen-Clozapine 12.5 mg (Clozapine TABLET (ORALLY DISINTEGRATING)) 12.5 MG

GEN-CLOZAPINE 12.5 MG is an orally disintegrating tablet used for managing certain mental health conditions. This medication is designed to dissolve quickly in the mouth, offering convenience for those who have difficulty swallowing pills.

Strength

12.5 MG

Manufacturer / TM Owner

MYLAN PHARMACEUTICALS ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

GEN-CLOZAPINE 12.5 MG is primarily used for the treatment of schizophrenia and other severe mental health disorders. It works by affecting certain chemicals in the brain to help improve symptoms. People often ask, 'What is clozapine used for?' and the answer is that it is typically prescribed for conditions where other treatments have not been effective.

Side Effects

Common effects of GEN-CLOZAPINE 12.5 MG may include drowsiness, dizziness, and increased salivation. Some users might experience weight gain or constipation. These effects can vary from person to person and may subside as the body adjusts to the medication.

Precautions & Warnings

It is important to handle GEN-CLOZAPINE 12.5 MG with care, especially if you have a history of seizures, heart disease, or low white blood cell count. Always follow the guidance of a healthcare professional regarding its use. Keep the medication out of reach of children and store it as directed.

Avoid Interactions

GEN-CLOZAPINE 12.5 MG may interact with other medications, including those that affect the central nervous system. Alcohol and certain antidepressants can also interact with clozapine. Always inform your healthcare provider about all the medications you are taking to avoid potential interactions.

Frequently Asked Questions

GEN-CLOZAPINE 12.5 MG is used to manage symptoms of schizophrenia and other severe mental health conditions.

GEN-CLOZAPINE 12.5 MG is an orally disintegrating tablet that should be placed on the tongue and allowed to dissolve without water.

Common side effects may include drowsiness, dizziness, increased salivation, weight gain, and constipation.

It is generally advised to avoid alcohol while taking GEN-CLOZAPINE 12.5 MG due to potential interactions.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.